No definition available.
Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)
C3_AML_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
351 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
351 |
4. Check minimum number of eventsNone |
351 |
5. Include endpoints |
351 |
6. Filter based on genotype QC (FinnGen only) |
351 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
- Control conditions
- not HLP_C3_AML
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Acute myeloid leukaemia, helper endpoint
- Acute myeloid leukaemia
- Acute myeloid leukaemia and myelodysplastic syndromes
- Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)
- Any event in cancer register
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 351 | 146 | 205 |
| Unadjusted period prevalence (%) | 0.07 | 0.05 | 0.09 |
| Median age at first event (years) | 65.55 | 57.84 | 71.03 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 359
- Matched controls
- 3589
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
323.0
313
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
620.9
300.1
260
15
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
+∞
295.1
241
*
XW000
NOMESCO Finland
Bone marrow biopsy
110.8
193.3
202
41
WW500
NOMESCO Finland
Blood transfusion
64.4
124.0
142
36
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
75.5
108.6
121
24
A04AA01
ATC
ondansetron; systemic, rectal
74.6
94.9
106
20
127
Kela drug reimbursment
Transplant complication
97.6
77.0
83
11
L03AA02
ATC
filgrastim; parenteral
442.6
74.7
72
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
+∞
71.3
66
*
A05AA02
ATC
ursodeoxycholic acid; oral
94.3
69.2
75
10
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
65.7
61
*
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
+∞
64.6
60
*
J05AB11
ATC
valaciclovir; oral
10.1
57.1
126
182
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
16.3
54.3
91
73
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
52.4
49
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.7
46.9
124
231
A49.9
ICD-10 Finland
Bacterial infection, unspecified
7.4
43.5
116
216
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
12.1
43.4
83
87
R50.9
ICD-10 Finland
Fever, unspecified
6.7
42.7
126
269
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
40.4
38
*
JN4BD
NOMESCO Finland
Extensive body CT
13.2
40.2
73
68
J01MA12
ATC
levofloxacin; systemic
5.7
39.4
136
349
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
+∞
38.2
36
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
17.3
38.0
61
42
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
33.1
37.6
49
17
ZX120
NOMESCO Finland
Intravenous
8.1
36.0
87
136
J02AC03
ATC
voriconazole; systemic
382.7
35.6
35
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
57.6
35.3
41
8
Z51.5
ICD-10 Finland
Palliative care
19.2
34.5
53
32
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
13.6
33.9
60
52
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
31.1
33.3
44
16
L04AD01
ATC
ciclosporin; systemic
24.9
32.7
46
21
WW200
NOMESCO Finland
Immunization
19.2
32.6
50
30
N02AA05
ATC
oxycodone; systemic
6.3
32.4
95
193
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
353.7
32.4
32
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
31.7
30
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
11.1
31.1
61
65
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
29.6
28
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
29.1
209
1000
H02AB02
ATC
dexamethasone; systemic
29.0
29.1
39
15
ZX112
NOMESCO Finland
Subcutaneous
39.8
29.0
36
10
C61
ICD-10 Finland
Malignant neoplasm of prostate
304.0
28.2
28
*
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
108.8
28.1
30
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
25.6
28.1
39
17
D64.9
ICD-10 Finland
Anaemia, unspecified
5.1
27.6
97
241
9891/3-C42.1
ICD-O-3
Acute monocytic leukemia of bone marrow
+∞
27.4
26
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
26.4
25
*
L01BB02
ATC
mercaptopurine; oral
48.3
26.0
31
7
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.5
25.6
104
298
C92.5
ICD-10 Finland
Acute myelomonocytic leukaemia
+∞
25.3
24
*
C92.4
ICD-10 Finland
Acute promyelocytic leukaemia [PML]
+∞
25.3
24
*
M04AA01
ATC
allopurinol; systemic
4.4
24.9
105
311
J02AC04
ATC
posaconazole; systemic
+∞
24.2
23
*
1DB06
NOMESCO Finland
NA
+∞
24.2
23
*
C95.9
ICD-10 Finland
Leukaemia, unspecified
+∞
24.2
23
*
A41.9
ICD-10 Finland
Sepsis, unspecified
8.3
23.6
54
75
A04AA02
ATC
granisetron; systemic, transdermal
+∞
23.2
22
*
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
23.2
22
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
22.1
21
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
22.1
21
*
2050A
ICD-9 Finland
Myeloid leukaemia, Acute
+∞
22.1
21
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
8.9
21.6
47
60
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
21.0
20
*
9873/3-C42.1
ICD-O-3
Acute myeloid leukemia without maturation of bone marrow
+∞
21.0
20
*
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
32.3
20.9
27
9
L04AA06
ATC
mycophenolic acid; systemic
24.1
20.7
29
13
TPX10
NOMESCO Finland
Implantation of vascular injection port
13.7
20.4
35
28
J02AC01
ATC
fluconazole; systemic
3.0
20.2
159
749
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
20.0
19
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
20.0
19
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
20.0
19
*
B73
ICPC
Leukaemia
+∞
20.0
19
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.1
19.9
143
633
A03FA01
ATC
metoclopramide; systemic, rectal
4.5
19.8
76
201
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
+∞
18.9
18
*
WW409
NOMESCO Finland
Other aferesis
+∞
18.9
18
*
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
200.0
18.7
19
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
8.1
18.1
41
56
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
28.4
18.1
24
9
115
Kela drug reimbursment
Breast cancer
+∞
17.9
17
*
2AX04
NOMESCO Finland
NA
188.9
17.7
18
*
TGC00
NOMESCO Finland
Bronchial lavation
9.3
16.9
35
41
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
94.5
16.7
18
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
31.7
16.3
21
7
A40.8
ICD-10 Finland
Other streptococcal sepsis
35.2
15.9
20
6
L01XX05
ATC
hydroxycarbamide; oral
20.4
15.8
23
12
1BC07
NOMESCO Finland
NA
+∞
15.7
15
*
116
Kela drug reimbursment
Prostate cancer
+∞
15.7
15
*
ZX121
NOMESCO Finland
Central venous catheter
89.1
15.7
17
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
89.1
15.7
17
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
89.1
15.7
17
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
15.6
136
658
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
8.4
15.5
34
44
J01MA14
ATC
moxifloxacin; systemic
4.3
15.2
59
156
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
26.3
14.8
20
8
JN4AD
NOMESCO Finland
Body CT examination
8.1
14.8
33
44
J05AB01
ATC
aciclovir; systemic
3.0
14.8
98
396
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
14.7
14
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.6
14.5
52
127
C93.0
ICD-10 Finland
Acute monoblastic/monocytic leukaemia
+∞
13.6
13
*
9866/3-C42.1
ICD-O-3
Acute promyelocytic leukemia, t(15;17)(q22;q11-12) of bone marrow
+∞
13.6
13
*
TPH00
NOMESCO Finland
Phlebotomy
35.6
13.6
17
5
R4110
NOMESCO Finland
Physiotherapy
2.6
13.1
115
548
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
17.6
13.1
20
12
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.7
13.0
101
450
D70.82
ICD-10 Finland
Drug-induced neutropenia
33.4
12.7
16
5
L02AE02
ATC
leuprorelin; implant, parenteral
25.4
12.6
17
7
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
12.6
12
*
9920/3-C42.1
ICD-O-3
Therapy-related myeloid neoplasm of bone marrow
+∞
12.6
12
*
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
134.5
12.5
13
*
C90.0
ICD-10 Finland
Multiple myeloma
134.5
12.5
13
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
12.4
97
430
9874/3-C42.1
ICD-O-3
Acute myeloid leukemia with maturation of bone marrow
+∞
11.5
11
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
11.5
11
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
11.5
11
*
L02BA01
ATC
tamoxifen; oral
123.8
11.5
12
*
1DB07
NOMESCO Finland
NA
123.8
11.5
12
*
H02AB09
ATC
hydrocortisone; systemic
8.1
11.4
25
33
212
Kela drug reimbursment
Gout
7.8
11.2
25
34
H02AB04
ATC
methylprednisolone; systemic
2.9
11.0
74
299
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
44.8
11.0
13
*
JN4CD
NOMESCO Finland
Very extensive body CT
12.5
11.0
19
16
L04AA01
ATC
[U] ciclosporin; systemic
11.1
10.9
20
19
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.7
10.9
31
59
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
22.3
10.8
15
7
WF002
NOMESCO Finland
Radical radiotherapy
61.9
10.7
12
*
N05BA06
ATC
lorazepam; systemic, sublingual
4.6
10.6
36
84
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
+∞
10.5
10
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.4
10.5
106
537
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.8
10.1
43
124
A41.8
ICD-10 Finland
Other specified sepsis
8.5
10.0
21
26
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
10.0
9.9
19
20
5BA08
NOMESCO Finland
NA
26.9
9.9
13
5
HA1AA
NOMESCO Finland
X-ray mammography
8.2
9.8
21
27
TAB00
NOMESCO Finland
Lumbar puncture
4.9
9.5
30
65
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.1
9.5
36
94
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.5
9.4
27
52
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
9.4
9
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
9.4
9
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
9.4
9
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
9.4
9
*
Y77
ICPC
Malignant neoplasm prostate
+∞
9.4
9
*
9867/3-C42.1
ICD-O-3
Acute myelomonocytic leukemia, NOS, of bone marrow
+∞
9.4
9
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
9.4
9
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.4
9.1
88
431
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
9.0
8.9
18
21
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
11.1
8.9
16
15
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
8.8
141
863
GD1AD
NOMESCO Finland
Thorax CT examination
5.8
8.8
24
44
J01MA02
ATC
ciprofloxacin; systemic
2.0
8.8
148
927
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
8.4
8
*
Z85.6
ICD-10 Finland
Personal history of leukaemia
+∞
8.4
8
*
L02BB03
ATC
bicalutamide; oral
+∞
8.4
8
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
8.4
8
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
8.4
8
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
8.4
8
*
A04AD12
ATC
aprepitant; systemic
+∞
8.4
8
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
8.4
8
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.8
8.4
35
100
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.0
8.3
32
85
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.1
8.3
46
162
ZX108
NOMESCO Finland
Inhalation
17.7
8.1
12
7
L02BG04
ATC
letrozole; oral
17.7
8.1
12
7
ED1AA
NOMESCO Finland
Mandipular X-ray examination
34.2
8.1
10
*
A98
ICPC
Health maint/preventive medicine
0.5
7.8
232
2817
A07AA02
ATC
nystatin; oral
3.8
7.8
32
90
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
46.0
7.7
9
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.0
7.7
45
165
306
Kela drug reimbursment
Erythropoietin and darbepoetin
25.6
7.6
10
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.8
7.5
48
188
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.1
7.4
27
69
130
Kela drug reimbursment
Malignant tumour
+∞
7.3
7
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
7.3
7
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
7.3
7
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
7.3
7
*
9895/3-C42.1
ICD-O-3
Acute myeloid leukemia with myelodysplasia-related changes of bone marrow
+∞
7.3
7
*
20500
ICD-8 Finland
Myeloid leukaemia, Acute
+∞
7.3
7
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
7.3
7
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
7.3
7
*
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
+∞
7.3
7
*
2AX05
NOMESCO Finland
NA
+∞
7.3
7
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.2
7.2
36
119
A02BC02
ATC
pantoprazole; systemic
1.8
6.8
213
1610
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
40.8
6.8
8
*
SPAT1088
SPAT
Blood transfusion
17.1
6.8
10
6
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.8
6.7
42
161
RS220
NOMESCO Finland
NA
8.0
6.7
14
18
D64.8
ICD-10 Finland
Other specified anaemias
7.1
6.6
15
22
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
71.1
6.4
7
*
B02AA02
ATC
tranexamic acid; systemic
2.5
6.3
49
212
NK6AN
NOMESCO Finland
Total body bone isotope imaging
18.4
6.3
9
5
B02.9
ICD-10 Finland
Zoster without complication
3.4
6.3
29
91
C92.3
ICD-10 Finland
Myeloid sarcoma
+∞
6.3
6
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
2AA01
NOMESCO Finland
NA
+∞
6.3
6
*
1BC01
NOMESCO Finland
NA
+∞
6.3
6
*
1CX01
NOMESCO Finland
NA
+∞
6.3
6
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
6.3
6
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
6.3
6
*
C92.7
ICD-10 Finland
Other myeloid leukaemia
+∞
6.3
6
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
6.3
6
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
6.3
6
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
6.3
6
*
D46.3
ICD-10 Finland
Refractory anemia with excess of blasts with transformation
+∞
6.3
6
*
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
+∞
6.3
6
*
N05CF01
ATC
zopiclone; oral
1.8
6.2
124
800
H02AB06
ATC
prednisolone; systemic
1.8
6.2
159
1114
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
3.1
6.2
33
115
B01AB05
ATC
enoxaparin; parenteral
1.9
6.2
97
574
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
6.0
161
1141
H02AB07
ATC
prednisone; oral
2.3
6.0
58
283
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(21494434) Karyotype in Bone marrow
104
24
61.16
180.72
1.3
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
112
38
42.82
176.09
7.0
1.9
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
88
18
64.91
156.05
1.3
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
88
20
58.39
152.55
2.8
2.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
93
42
29.76
131.30
1.4
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
88
35
33.22
130.00
1.5
1.7
u/ml
101.9
98.6
—
24
7
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
88
37
31.41
127.40
1.3
1.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
85
40
27.72
117.66
1.4
1.5
u/ml
243.6
174.8
1.28
54
21
(3048929) Epstein Barr virus Ab [Presence] in Serum
95
63
20.30
112.80
1.4
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
74
45
20.57
90.92
4.5
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
71
40
22.00
90.34
1.3
1.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
74
49
18.87
87.09
4.2
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
63
34
22.36
81.45
4.5
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
115
166
9.82
81.18
9.9
4.6
%
1.5
0.8
1.36
70
38
(3016650) Hepatitis A virus Ab [Presence] in Serum
66
40
20.09
80.92
1.3
1.1
—
—
—
0
0
(44806118)
48
19
29.11
69.78
2.6
1.4
—
—
—
0
0
(44790047)
48
19
29.11
69.78
2.6
1.4
—
—
—
0
0
(44790049)
48
19
29.11
69.78
2.6
1.4
—
—
—
0
0
(44790048)
48
19
29.11
69.78
2.6
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
69
60
14.07
69.27
1.5
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
92
129
9.31
65.64
1.4
1.4
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
49
24
23.57
65.63
9.5
3.8
%
0.8
0.7
0.09
43
19
(3045142) Bone marrow Pathology biopsy report
46
20
26.32
64.53
1.6
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
121
235
7.33
64.49
8.8
2.2
e9/l
60.4
67.4
0.79
101
193
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
41
14
33.03
62.40
1.9
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
43
20
24.36
58.64
3.0
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
92
147
8.13
58.36
10.0
4.9
%
0.8
0.3
1.82
43
29
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
45
24
21.36
57.97
2.7
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
94
156
7.86
57.59
10.5
4.8
%
0.2
0.1
0.91
66
33
(3017143) Hepatitis C virus Ab [Presence] in Serum
113
229
6.80
57.17
1.6
1.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
136
346
5.78
53.65
14.5
2.9
mmol/l
0.8
0.8
0.57
129
320
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
39
19
22.97
52.06
5.1
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
88
151
7.44
51.98
10.0
4.8
%
7.0
3.0
0.50
50
29
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
78
119
8.14
51.19
1.7
1.7
g/l
1.6
1.5
0.30
67
101
(3024932) HLA-DR beta [Type]
54
6
106.05
50.45
1.4
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
54
6
106.05
50.45
1.0
1.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
114
262
5.96
49.98
1.6
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
39
21
20.77
49.85
5.1
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
39
21
20.77
49.85
9.3
3.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
45
35
14.60
47.75
2.0
1.3
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
31
10
33.91
47.69
5.1
1.4
%
25.5
—
—
11
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
38
23
18.41
45.94
1.3
1.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
84
174
6.03
40.58
4.0
1.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
28
11
27.57
40.28
6.9
1.3
e9/l
1.2
0.7
—
13
5
(4035726)
51
65
9.01
38.50
1.7
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
30
17
19.20
37.23
9.9
2.9
%
39.7
47.3
0.40
22
12
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
30
17
19.20
37.23
1.9
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
35
27
14.29
37.09
2.0
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
112
326
4.58
35.97
1.7
1.8
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
30
20
16.31
34.35
4.9
1.9
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
28
18
16.82
32.61
1.2
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
177
762
3.67
31.89
28.4
5.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
165
680
3.69
31.78
23.4
3.9
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
35
5
77.35
31.51
1.3
1.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
158
670
3.47
28.46
11.0
2.6
umol/l
315.0
9246.2
3.88
152
574
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
47
77
6.89
28.32
3.3
3.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
27
21
13.85
28.31
6.1
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
27
21
13.85
28.31
6.1
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
27
21
13.85
28.31
6.1
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
24
16
16.03
27.33
1.4
1.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
24
16
16.03
27.33
1.4
1.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
44
72
6.84
26.50
2.5
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
116
428
3.55
25.65
4.4
1.7
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
208
1095
3.21
25.26
26.4
5.7
%
10.5
8.7
2.50
202
1009
(3002030) Lymphocytes/100 leukocytes in Blood
209
1117
3.15
24.46
25.4
5.5
%
33.1
27.2
6.86
203
1027
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
28
29
10.41
24.42
2.2
1.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
205
1090
3.12
24.10
24.7
5.4
%
1.8
2.9
15.50
200
1002
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
90
294
3.77
23.75
3.1
1.8
—
—
—
0
0
(3048879) Bone marrow aspiration report
28
6
50.53
23.69
6.5
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
29
33
9.49
23.62
2.2
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
128
533
3.21
22.90
3.2
1.7
mg/l
4.4
1.2
2.44
115
400
(3000093) Morphology [Interpretation] in Blood Narrative
26
27
10.32
22.60
1.3
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
112
438
3.29
22.17
1.5
1.3
g/l
2.4
2.7
0.79
98
251
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
23
21
11.65
21.77
1.3
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
87
296
3.58
21.43
3.0
1.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
26
8
34.94
20.49
7.2
3.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
148
705
2.90
20.43
18.1
2.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
24
5
51.29
20.42
1.3
1.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
19
14
14.29
20.37
7.7
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
19
14
14.29
20.37
7.7
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
19
14
14.29
20.37
7.7
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
19
14
14.29
20.37
7.7
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
20
17
12.42
19.74
1.4
1.2
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
196
1108
2.74
19.08
23.6
5.3
%
47.0
57.8
15.83
190
1021
(3004588) Protein electrophoresis panel - Serum or Plasma
61
176
3.98
18.98
1.3
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
19
16
12.50
18.84
1.1
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
16
10
16.72
18.61
1.1
1.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
120
541
2.85
17.98
15.6
2.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
16
12
13.92
16.90
1.1
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
182
1035
2.58
16.87
24.6
3.5
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
21
7
31.77
16.30
8.1
1.4
e9/l
0.2
0.2
—
21
7
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
22
9
25.96
16.21
1.6
1.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
212
1317
2.54
15.98
57.1
6.2
e9/l
2.9
4.3
3.05
202
1144
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
21
28
7.91
14.99
7.1
1.8
pg
33.2
34.4
0.47
21
28
(40760892) CBC W Ordered Manual Differential panel - Blood
106
488
2.68
14.87
16.8
4.3
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
20
9
23.46
14.38
50.9
34.2
ug/l
154.8
137.9
—
20
9
(3013115) Eosinophils [#/volume] in Blood
197
1221
2.40
14.38
27.2
5.4
e9/l
0.1
0.2
10.09
179
1074
(3001604) Monocytes [#/volume] in Blood
191
1174
2.38
14.13
22.5
5.1
e9/l
0.8
0.6
0.37
176
1011
(3006315) Basophils [#/volume] in Blood
191
1181
2.35
13.84
22.5
5.2
e9/l
0.0
0.0
7.23
176
1021
(3001964) Herpes simplex virus Ag [Presence] in Specimen
17
5
35.60
13.62
2.2
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
23
38
6.41
13.57
3.1
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
191
1203
2.29
12.97
22.9
5.2
e9/l
2.0
1.8
0.25
179
1059
(3042936) Bacteria identified in Isolate by Culture
83
360
2.71
12.92
2.4
1.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
114
579
2.43
12.76
2.4
1.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
18
9
20.99
12.58
7.9
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
18
9
20.99
12.58
7.9
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
18
9
20.99
12.58
7.9
1.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
193
1236
2.25
12.40
21.6
5.5
mmol/l
1.2
1.2
0.23
167
1051
(3024561) Albumin [Mass/volume] in Serum or Plasma
170
1040
2.23
12.16
20.1
3.7
g/l
32.4
35.4
7.92
164
954
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
179
1128
2.20
11.78
18.7
5.2
mmol/l
1.2
1.2
1.18
172
994
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
24
48
5.29
11.64
1.6
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
22
41
5.66
11.50
2.3
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
128
717
2.24
11.17
18.6
3.1
ph
7.4
7.4
1.00
22
111
(3000494) Fungus identified in Specimen by Culture
64
262
2.76
11.04
3.3
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
16
9
18.55
10.82
2.8
1.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
16
9
18.55
10.82
2.8
1.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
129
734
2.20
10.76
6.7
2.7
u/l
30.0
34.3
1.14
124
696
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
52
194
2.97
10.62
1.9
2.1
g/l
0.2
0.2
0.59
46
170
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
14
6
24.21
10.32
3.0
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
14
6
24.21
10.32
3.0
1.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
13
5
26.90
9.88
3.7
1.6
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
13
5
26.90
9.88
3.7
1.6
%
15.8
4.0
—
13
5
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
13
16
8.40
9.80
3.1
1.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
74
347
2.44
9.60
1.5
2.3
g/l
2.0
2.3
4.01
69
318
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
70
324
2.45
9.33
1.6
2.4
%
38.7
23.5
4.82
54
285
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
23
55
4.40
9.06
1.6
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
23
55
4.40
9.06
1.6
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
13
7
19.22
9.00
2.7
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
20
43
4.87
8.94
8.1
3.1
%
41.6
60.2
4.02
20
43
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
21
48
4.59
8.74
2.6
1.3
mmol/l
3.8
4.0
0.42
21
42
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
10
10
10.26
8.68
6.2
1.5
u/l
197.5
193.0
—
10
10
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
21
50
4.40
8.31
4.2
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
16
30
5.54
8.28
5.0
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
62
286
2.42
8.28
1.9
1.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
12
17
7.27
8.04
3.2
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
16
31
5.36
8.00
5.0
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
16
31
5.36
8.00
5.0
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
16
31
5.36
8.00
5.0
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
16
31
5.36
8.00
5.0
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
16
31
5.36
8.00
5.0
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
155
1045
1.87
7.40
10.0
10.1
inr
1.2
1.4
0.88
39
287
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
23
65
3.72
7.27
1.1
1.2
—
1.5
—
0
6
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
10
5
20.52
7.17
1.2
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
10
13
7.89
7.15
2.3
1.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
18
43
4.36
7.10
1.2
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
11
17
6.65
6.81
3.5
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
14
7.32
6.73
2.9
1.8
u/ml
1224.6
715.0
—
10
14
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
197
2443
0.56
6.51
4.7
5.2
mmol/l
2.6
2.6
0.01
184
2216
(3015377) Calcium [Moles/volume] in Serum or Plasma
120
781
1.82
6.19
6.1
2.0
mmol/l
2.3
2.4
2.92
108
626
(3001122) Ferritin [Mass/volume] in Serum or Plasma
149
1036
1.76
6.13
4.3
2.6
ug/l
860.9
127.6
3.73
140
948
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
20
58
3.60
6.10
1.2
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
233
2743
0.55
6.09
88.1
19.5
e9/l
10.3
6.8
0.61
227
2646
(3026361) Erythrocytes [#/volume] in Blood
233
2742
0.55
6.06
88.2
19.5
e12/l
3.7
4.5
37.34
227
2646
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
12
23
5.37
6.05
1.7
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
233
2741
0.55
6.03
88.2
19.5
e9/l
162.0
242.7
21.82
227
2652
(3037756) Immunofixation for Serum or Plasma
16
40
4.14
5.96
1.1
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
6
15.34
5.93
1.3
1.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
93
567
1.87
5.87
44.2
4.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
84
2.99
5.47
3.7
3.2
u/ml
0.3
0.4
0.29
12
49
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
30
119
2.66
5.45
7.3
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
193
2362
0.59
5.35
4.4
4.6
mmol/l
1.3
1.4
6.26
179
2143
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
8
11.50
5.32
1.8
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
8
11.50
5.32
3.0
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
9
8
11.50
5.32
3.0
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
186
2295
0.60
5.29
5.2
6.4
mmol/mol
40.1
40.9
0.64
171
2101
(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
5
0
+∞
5.22
7.6
0.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
8
6
13.60
5.10
1.0
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
30
124
2.55
5.03
3.6
1.4
ug/l
3.3
5.2
0.32
25
91
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
36
163
2.35
4.98
1.6
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
15
41
3.78
4.98
1.1
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
198
2392
0.60
4.97
5.6
4.7
mmol/l
6.0
6.1
0.16
182
2137
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
103
678
1.73
4.95
2.3
2.1
mg/l
2.7
3.1
1.05
83
568
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
19
63
3.13
4.75
1.2
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
27
110
2.58
4.67
1.5
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
11
8.36
4.58
3.0
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
220
2574
0.61
4.56
46.4
12.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
115
800
1.65
4.43
4.2
3.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
200
2385
0.62
4.39
5.0
4.6
mmol/l
4.3
4.5
1.12
188
2172
(3042631) Mycobacterium sp identified in Specimen
10
22
4.65
4.33
1.8
3.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
83
533
1.73
4.29
4.8
3.9
ng/l
96.3
353.5
1.27
74
439
(3008152) Bicarbonate [Moles/volume] in Arterial blood
36
174
2.19
4.29
9.4
6.6
mmol/l
24.8
24.8
0.01
36
164
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
126
904
1.61
4.26
5.4
3.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
190
2285
0.63
4.25
50.9
12.0
ml/min/173m2
79.4
76.7
0.83
161
1843
(3016244) Insulin [Units/volume] in Serum or Plasma
8
10
8.15
4.08
5.1
2.4
mu/l
20.4
13.6
—
8
10
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
227
2614
0.63
4.03
43.6
8.9
u/l
29.0
25.0
3.18
220
2487
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
191
2277
0.65
3.89
5.5
4.5
mu/l
1.9
2.0
0.04
178
2038
(3028433) Virus identified in Specimen by Culture
8
11
7.41
3.88
1.1
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
11
7.41
3.88
1.4
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
25
108
2.42
3.86
3.2
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
15
6.13
3.84
5.1
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
34
169
2.12
3.79
1.6
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
36
183
2.08
3.79
6.4
4.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
8
8.90
3.79
1.3
1.3
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
5
12.17
3.77
2.3
7.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
12
6.79
3.69
1.4
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
107
763
1.58
3.62
4.2
2.2
u/l
48.1
57.9
2.47
97
703
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
17
5.40
3.53
1.1
1.0
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
6
10.14
3.51
1.2
1.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
49
287
1.82
3.44
8.6
6.6
mmol/l
1.3
1.7
0.27
39
221
(3006922) Hepatitis E virus Ab [Presence] in Serum
7
10
7.12
3.38
1.1
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
32
3.52
3.36
1.1
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
45
259
1.85
3.34
5.0
4.0
mmol/l
1.4
2.1
0.45
35
204
(3002173) Hemoglobin [Mass/volume] in Arterial blood
41
229
1.89
3.34
9.4
6.4
g/l
99.5
123.0
9.39
41
222
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
64
410
1.69
3.30
5.2
2.8
e6/l
3.2
3.0
0.04
37
229
(1761868) Lipid panel - Serum or Plasma
48
762
0.57
3.26
4.1
3.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
41
232
1.87
3.21
2.0
1.8
nmol/l
410.4
365.0
0.88
41
211
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
196
2281
0.68
3.09
5.4
4.1
mmol/l
1.6
1.3
5.34
183
2055
(3000991) Gas panel - Venous blood
36
198
1.91
3.07
10.3
8.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
229
2584
0.67
3.02
57.8
16.4
mmol/l
138.7
139.7
6.18
224
2492
(3009871) Measles virus Ab [Titer] in Serum
5
5
10.12
2.98
1.8
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
108
2.21
2.98
1.4
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
85
600
1.55
2.95
1.9
1.7
nmol/l
1322.4
1166.8
0.69
76
451
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
9
6.76
2.88
1.3
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
9
6.76
2.88
1.2
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
9
6.76
2.88
1.3
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
9
6.76
2.88
1.0
1.1
nmol/l
112.8
121.7
—
6
9
(3021589) Normoblasts [#/volume] in Blood
135
1059
1.45
2.78
40.3
7.8
e9/l
0.0
0.0
0.79
113
855
(3019225) pH of Specimen
42
252
1.76
2.74
11.7
3.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
7
14
5.08
2.74
12.6
1.9
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
24
119
2.09
2.73
11.4
9.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
104
779
1.48
2.71
5.4
2.9
e6/l
63.6
150.3
0.50
83
606
(40768804) Tissue Pathology biopsy report
98
727
1.48
2.67
2.7
1.6
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
17
74
2.36
2.62
1.5
1.2
g/l
0.0
0.0
0.00
17
69
(3017704) Immunofixation for Urine
7
15
4.74
2.61
1.0
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
25
3.67
2.59
4.7
4.7
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
7
7.23
2.55
1.6
5.6
%
110.6
90.0
—
5
7
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
11
5.53
2.55
1.0
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
29
159
1.90
2.52
3.2
1.6
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
16
4.44
2.48
1.1
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
28
153
1.90
2.46
1.6
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
29
489
0.56
2.41
1.3
1.2
u/ml
0.8
1.5
—
6
131
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
17
77
2.27
2.41
1.5
1.2
g/l
0.0
0.0
0.00
17
70
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
6
12
5.07
2.41
1.2
1.1
u/l
13.2
15.8
—
6
12
(3030467) Casts [#/volume] in Urine by Automated count
94
705
1.46
2.40
5.5
2.9
e6/l
0.3
0.5
0.36
73
525
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
8
6.32
2.38
1.0
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
156
1846
0.72
2.37
5.0
3.7
pmol/l
14.8
14.9
0.31
144
1653
(36304419) Bacteria [Presence] in Urine
89
663
1.46
2.35
5.6
2.8
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
18
3.94
2.26
13.0
2.5
—
—
—
0
0
(4027681)
7
18
3.94
2.26
1.3
1.2
—
—
—
0
0
(4094501)
0
61
0.00
2.26
0.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
9
5.62
2.22
1.2
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
9
5.62
2.22
1.2
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
17
81
2.15
2.16
1.3
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
25
138
1.87
2.15
5.7
4.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9
208
0.42
2.15
2.2
2.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
62
438
1.50
2.13
5.2
2.6
e6/l
1.5
1.1
0.16
36
258
(1616796) Gas panel - Central venous blood
12
49
2.50
2.12
5.8
2.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
61
836
0.67
2.10
3.0
4.1
mg/mmol
5.0
9.1
1.41
39
537
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
17
82
2.13
2.10
1.5
1.2
g/l
0.0
0.1
0.49
17
75
(3014765) Yersinia sp identified in Stool by Organism specific culture
17
82
2.13
2.10
1.3
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
47
314
1.57
2.07
1.3
1.3
titre
669.1
442.0
0.44
11
79
(3009343) pH of Capillary blood
31
186
1.73
2.05
5.4
4.5
ph
7.4
7.4
—
5
15
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
32
2.86
2.01
1.1
1.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
188
0.41
1.99
2.4
2.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
17
84
2.08
1.99
1.3
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
51
2.40
1.97
1.0
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
45
2.49
1.95
1.2
1.4
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
5
11
4.59
1.94
2.0
2.3
umol/l
25.6
26.3
—
5
11
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
11
4.59
1.94
1.6
1.3
ug/l
14.7
11.7
—
5
11
(40768800) Prostate Pathology biopsy report
5
11
4.59
1.94
1.4
1.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
189
1639
1.33
1.91
6.6
4.5
e6/l
320.1
3995.7
—
7
29
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
11
234
0.45
1.87
1.7
1.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
111
900
1.34
1.75
6.2
3.5
e6/l
56.7
137.9
0.97
86
650
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
137
1148
1.32
1.71
2.2
2.1
pmol/l
85.6
93.4
1.36
100
575
(3044889) 12 lead EKG panel
150
1734
0.76
1.70
6.8
3.9
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
64
839
0.71
1.70
2.4
3.2
mmol/l
7.0
7.5
0.37
59
700
(3012516) Albumin [Mass/volume] in Urine
60
794
0.71
1.68
2.4
3.3
mg/l
1150.1
278.3
0.37
42
525
(3024891) Influenza virus A+B Ag [Presence] in Specimen
13
62
2.14
1.67
1.4
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
198
2202
0.77
1.64
62.1
14.6
%
33.2
39.8
13.32
124
1487
(36660697) Celiac disease serology panel - Serum
8
175
0.44
1.62
1.4
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
21
2.89
1.51
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
21
2.89
1.51
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
21
2.89
1.51
1.0
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
21
124
1.74
1.51
6.6
5.1
mmol/l
25.0
24.8
0.11
21
117
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
76
947
0.75
1.44
4.5
3.9
ug/l
2.3
2.1
0.29
68
835
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
22
2.76
1.44
1.0
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
22
2.76
1.44
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
22
2.76
1.44
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
22
2.76
1.44
1.0
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
230
2492
0.78
1.43
70.0
13.3
mg/l
36.7
24.2
4.92
218
1948
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
57
741
0.72
1.43
4.3
3.8
%
20.1
24.8
1.20
28
360
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
40
2.28
1.41
1.1
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
29
2.44
1.40
1.1
1.3
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
5
17
2.97
1.36
1.2
1.1
u/l
368.6
303.8
—
5
17
(3021788) Differential panel - Synovial fluid
10
48
2.12
1.29
1.3
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
157
0.50
1.28
3.1
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
118
0.42
1.27
2.8
1.5
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
6
25
2.42
1.25
1.7
1.2
g/l
5.5
6.9
—
6
19
(3028192) IgG subclass 2 [Mass/volume] in Serum
6
25
2.42
1.25
1.7
1.2
g/l
1.7
2.8
—
6
19
(4062490)
6
25
2.42
1.25
1.7
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
23
148
1.59
1.23
2.1
2.4
e6/l
1.3
0.2
0.51
23
143
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
122
1406
0.80
1.22
3.6
2.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
20
125
1.64
1.20
1.4
1.3
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
20
2.52
1.15
1.2
1.1
—
—
—
0
0
(3020891) Body temperature
18
111
1.66
1.14
6.5
4.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
38
508
0.72
1.13
3.0
2.7
ug/l
0.9
0.8
0.18
24
359
(3049717) Cytology report of Urine Cyto stain
14
81
1.76
1.10
2.4
1.7
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
32
2.21
1.08
1.0
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
11
59
1.89
1.08
2.0
1.7
g/l
109.8
135.1
2.20
11
40
(3000492) Spirometry study
28
195
1.47
1.08
1.7
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
13
74
1.79
1.08
1.4
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
33
2.14
1.06
2.1
2.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
12
67
1.82
1.06
9.0
3.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
9
46
1.98
1.04
2.8
2.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
9
48
1.90
1.01
1.3
1.3
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
17
108
1.60
0.98
1.1
1.3
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
0
31
0.00
0.97
0.0
3.5
—
17.6
—
0
25
(3000330) Specific gravity of Urine by Test strip
8
142
0.55
0.95
6.1
3.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
32
0.00
0.95
0.0
1.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
27
2.24
0.94
1.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
27
2.24
0.94
1.0
1.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
12
70
1.74
0.93
8.4
5.8
mg/l
1.2
1.5
1.53
12
63
(3043409) Potassium [Moles/volume] in Arterial blood
14
86
1.65
0.92
6.6
4.4
mmol/l
3.5
3.9
2.50
14
79
(3026389) Candida sp identified in Specimen by Organism specific culture
6
28
2.16
0.92
2.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
10
169
0.58
0.91
2.2
2.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
31
230
1.38
0.88
3.3
3.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
25
0.00
0.79
0.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
25
0.00
0.79
0.0
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
27
0.00
0.77
0.0
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
57
472
1.25
0.77
2.7
2.2
mmol/l
2.4
2.4
0.05
49
391
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
28
0.00
0.76
0.0
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
28
0.00
0.76
0.0
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
28
0.00
0.76
0.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
28
0.00
0.76
0.0
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
10
159
0.62
0.74
1.3
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
5
25
2.01
0.73
1.0
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
7
39
1.81
0.73
1.1
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
14
205
0.67
0.72
5.0
2.4
ml/min/173m2
62.2
60.3
—
6
88
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
22
161
1.39
0.70
1.3
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
5
27
1.86
0.68
1.8
1.1
e6/l
3746.8
1827.5
—
5
17
(4034850)
5
91
0.54
0.68
9.4
11.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
28
1.80
0.66
1.0
1.3
—
—
—
0
0
(4024509)
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
(4146454)
0
22
0.00
0.59
0.0
3.3
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
23
0.00
0.58
0.0
2.5
—
150.2
—
0
5
(3024980) IgG subclass 4 [Mass/volume] in Serum
6
39
1.55
0.53
1.8
1.2
g/l
0.5
0.6
—
6
33
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
117
1072
1.14
0.51
3.7
3.8
ng/l
32.7
72.6
0.67
90
768
(3008898) HLA-B27 [Presence]
5
83
0.60
0.46
1.0
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
35
414
0.83
0.45
1.2
1.3
iu/ml
14.0
33.5
2.84
12
142
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
8
56
1.44
0.43
3.1
1.8
u/ml
11.1
17.6
—
8
42
(3013139) Helicobacter pylori Ag [Presence] in Stool
11
150
0.72
0.42
1.0
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
111
1028
1.12
0.41
2.7
2.3
nmol/l
74.5
76.3
0.27
100
893
(3032773) Endomysium IgG Ab [Titer] in Serum
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
34
1.48
0.40
1.8
2.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
34
1.48
0.40
1.0
1.1
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
0
18
0.00
0.40
0.0
2.1
—
2.5
—
0
13
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
35
1.43
0.39
1.0
1.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
91
836
1.12
0.38
3.3
2.1
u/l
136.4
320.3
1.15
85
777
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
33
383
0.85
0.36
1.2
1.3
u/ml
1.0
12.6
—
7
146
(40761536) Microorganisms panel - Urine sediment
23
191
1.22
0.34
3.6
3.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
36
405
0.88
0.28
20.1
27.8
inr
1.1
1.4
—
7
58
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
8
63
1.28
0.28
1.3
1.1
—
3.9
—
0
9
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
8
65
1.24
0.27
1.3
1.1
—
10.6
—
0
11
(3048689) Calprotectin [Mass/mass] in Stool
29
253
1.16
0.27
1.5
2.0
ug/g
103.4
127.8
0.40
21
197
(3011397) Hemoglobin [Presence] in Urine by Test strip
61
562
1.10
0.25
3.9
3.9
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
65
601
1.10
0.25
1.6
1.8
pmol/l
464.4
11753004.3
0.50
54
485
(40768443) Skin Pathology biopsy report
13
105
1.25
0.25
1.4
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
69
643
1.09
0.23
3.5
4.1
estimate
0.0
0.0
0.00
22
188
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
10
79
1.27
0.22
1.1
2.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
5
40
1.25
0.22
1.4
2.4
%
54.0
64.0
—
5
40
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
41
1.22
0.22
1.2
1.5
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
9.1
—
0
11
(3022689) Creatine [Moles/volume] in Urine
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(4015189)
0
10
0.00
0.21
0.0
2.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
105
0.76
0.21
2.3
2.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
39
355
1.11
0.21
1.5
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
192
1866
1.06
0.21
5.0
4.1
mm/h
26.0
12.5
10.03
180
1692
(3035320) C reactive protein [Mass/volume] in Body fluid
0
13
0.00
0.21
0.0
2.6
—
—
—
0
0
(3015736) pH of Urine
100
952
1.07
0.20
3.6
3.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
6
48
1.25
0.20
1.3
3.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
12
99
1.22
0.20
1.3
2.6
g/l
0.3
0.3
—
5
34
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
52
1.16
0.19
1.2
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
53
1.13
0.19
1.8
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
24
268
0.89
0.18
1.9
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
27
243
1.12
0.18
8.3
3.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
77
0.78
0.15
2.0
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
77
0.78
0.15
2.0
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
80
0.75
0.15
1.5
1.6
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
7
86
0.81
0.14
1.1
1.3
—
0.2
—
0
8
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
15
134
1.12
0.11
7.3
2.6
%
1.4
1.2
0.59
15
134
(4010399)
15
167
0.89
0.11
1.7
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
44
1.14
0.10
4.0
2.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
44
1.14
0.10
1.2
1.6
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
44
1.14
0.10
4.0
2.2
mmol/l
3.8
4.1
—
5
44
(3035285) Chloride [Moles/volume] in Venous blood
5
44
1.14
0.10
4.0
2.2
mmol/l
107.4
105.0
—
5
44
(3011288) Drugs identified in Urine by Screen method
5
48
1.04
0.09
3.0
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
55
572
0.95
0.09
3.7
4.2
kg/l
1.0
1.0
—
9
86
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
85
1.06
0.07
1.7
1.9
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
117
1191
0.97
0.06
5.6
5.2
estimate
0.0
0.0
0.00
22
190
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
34
325
1.05
0.06
3.0
4.9
%
26.4
32.2
2.44
27
204
(3037467) Urinalysis macro (dipstick) panel - Urine
173
1712
1.02
0.05
6.6
4.3
—
—
—
0
0
(3013512) EKG study
76
773
0.98
0.03
4.7
3.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
121
1196
1.02
0.03
3.8
3.8
estimate
0.0
0.0
0.00
24
199
(3009261) Glucose [Presence] in Urine by Test strip
120
1214
0.98
0.03
3.9
3.8
estimate
0.0
0.0
0.00
22
192
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
141
1.07
0.03
2.5
2.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
94
927
1.02
0.03
3.7
4.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
64
652
0.98
0.03
3.2
3.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
153
1518
1.01
0.02
4.9
3.0
u/l
66.6
46.9
1.56
143
1393
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
33
336
0.98
0.00
14.8
7.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
21
211
0.99
0.00
1.2
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
32
323
0.99
0.00
1.3
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
7
75
0.93
0.00
1.9
1.5
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.2
—
5.8
—
0
6
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
7.5
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
5.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
5
0.00
0.00
0.0
1.6
—
8.0
—
0
5
(3003327) Ova and parasites identified in Stool by Light microscopy
6
59
1.02
0.00
1.7
1.5
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
8
85
0.94
0.00
1.1
1.1
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
30.6
—
0
8
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
6
62
0.97
0.00
2.8
2.3
umol/l
31.7
33.9
—
6
52
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
7
76
0.92
0.00
2.0
1.4
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
6
0.00
0.00
0.0
1.0
—
3.4
—
0
6
(3014599) Egg white IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
83
0.96
0.00
5.5
4.3
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
7.3
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.9
—
16.4
—
0
9
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_AML_EXALLC – Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).